239 related articles for article (PubMed ID: 21513619)
21. "Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products".
Fuenffinger N; Ritchie M; Ruth A; Gryniewicz-Ruzicka C
J Pharm Biomed Anal; 2017 Feb; 134():282-286. PubMed ID: 27951469
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.
Godoy AL; De Moraes NV; Martinez EZ; Carvalho TM; Marques MP; Lanchote VL
Chirality; 2011 Apr; 23(4):287-93. PubMed ID: 21384434
[TBL] [Abstract][Full Text] [Related]
23. Glucuronidation of racemic O-desmethyltramadol, the active metabolite of tramadol.
Lehtonen P; Sten T; Aitio O; Kurkela M; Vuorensola K; Finel M; Kostiainen R
Eur J Pharm Sci; 2010 Nov; 41(3-4):523-30. PubMed ID: 20797434
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry.
Lu S; Tran BN; Nelsen JL; Aldous KM
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2499-505. PubMed ID: 19577523
[TBL] [Abstract][Full Text] [Related]
25. Determination of Mitragynine in
Mudge EM; Brown PN
J AOAC Int; 2017 Jan; 100(1):18-24. PubMed ID: 27725074
[TBL] [Abstract][Full Text] [Related]
26. Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection.
Chytil L; Matousková O; Cerná O; Pokorná P; Vobruba V; Perlík F; Slanar O
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):481-6. PubMed ID: 20018572
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats.
Valle M; Garrido MJ; Pavón JM; Calvo R; Trocóniz IF
J Pharmacol Exp Ther; 2000 May; 293(2):646-53. PubMed ID: 10773040
[TBL] [Abstract][Full Text] [Related]
28. Quantification in postmortem blood and identification in urine of tramadol and its two main metabolites in two cases of lethal tramadol intoxication.
De Backer B; Renardy F; Denooz R; Charlier C
J Anal Toxicol; 2010 Nov; 34(9):599-604. PubMed ID: 21073815
[TBL] [Abstract][Full Text] [Related]
29. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.
Kruegel AC; Grundmann O
Neuropharmacology; 2018 May; 134(Pt A):108-120. PubMed ID: 28830758
[TBL] [Abstract][Full Text] [Related]
30. Mitragynine 'Kratom' related fatality: a case report with postmortem concentrations.
McIntyre IM; Trochta A; Stolberg S; Campman SC
J Anal Toxicol; 2015 Mar; 39(2):152-5. PubMed ID: 25516573
[TBL] [Abstract][Full Text] [Related]
31. Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics.
de Moraes NV; Lauretti GR; Napolitano MN; Santos NR; Godoy AL; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):140-7. PubMed ID: 22173007
[TBL] [Abstract][Full Text] [Related]
32. Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Mass Spectrom; 2010 Nov; 45(11):1344-57. PubMed ID: 20967737
[TBL] [Abstract][Full Text] [Related]
33. CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S; Kerrigan S
J Anal Toxicol; 2020 May; 44(4):301-313. PubMed ID: 32008041
[TBL] [Abstract][Full Text] [Related]
34. Metabolism studies of the Kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1049-55. PubMed ID: 21450536
[TBL] [Abstract][Full Text] [Related]
35. Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
Philipp AA; Wissenbach DK; Zoerntlein SW; Klein ON; Kanogsunthornrat J; Maurer HH
J Mass Spectrom; 2009 Aug; 44(8):1249-61. PubMed ID: 19536806
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of tramadol, O-desmethyltramadol and N-desmethyltramadol in human urine by gas chromatography-mass spectrometry.
El-Sayed AA; Mohamed KM; Nasser AY; Button J; Holt DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():9-15. PubMed ID: 23542669
[TBL] [Abstract][Full Text] [Related]
39. Two Single-Drug Fatal Intoxications by Mitragynine.
Behonick GS; Vu C; Czarnecki L; El-Ters M; Shanks KG
J Anal Toxicol; 2022 May; 46(5):e110-e114. PubMed ID: 35285475
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive methodology for identification of Kratom in police laboratories.
Kowalczuk AP; Łozak A; Zjawiony JK
Forensic Sci Int; 2013 Dec; 233(1-3):238-43. PubMed ID: 24314525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
